These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14200614)

  • 21. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 22. Prior DNA vaccination does not interfere with the live-attenuated measles vaccine.
    Premenko-Lanier M; Rota P; Rhodes G; Bellini W; McChesney M
    Vaccine; 2004 Jan; 22(5-6):762-5. PubMed ID: 14741170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
    BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
    JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
    [No Abstract]   [Full Text] [Related]  

  • 24. Mumps vaccination.
    Hilleman MR
    Mod Trends Med Virol; 1970; 2(0):241-61. PubMed ID: 5527958
    [No Abstract]   [Full Text] [Related]  

  • 25. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 26. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
    [No Abstract]   [Full Text] [Related]  

  • 27. [EXPERIENCE IN VACCINATION WITH ATTENUATED MEASLES VIRUS. 3. IMMUNOLOGIC AND EPIDEMIOLOGIC STUDY AFTER A YEAR OF OBSERVATION].
    HEVIA P; RODRIGUEZ M; UNDURRAGA O; ROSSELOT J; MENEGHELLO J
    Pediatria (Santiago); 1963; 6():151-6. PubMed ID: 14080014
    [No Abstract]   [Full Text] [Related]  

  • 28. MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC.
    RAUH LW; SCHMIDT R
    Am J Dis Child; 1965 Mar; 109():232-7. PubMed ID: 14246070
    [No Abstract]   [Full Text] [Related]  

  • 29. Measles vaccines used in Japan.
    Hirayama M
    Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DATA OF THE INVESTIGATION ON THE EFFECTIVENESS OF ACTIVE IMMUNIZATION AGAINST MEASLES WITH VARIOUS LIVE VACCINES AND COMBINATIONS THEREOF.
    FADEEVA LL; ZHDANOV VM
    Arch Gesamte Virusforsch; 1965; 16():524-6. PubMed ID: 14322928
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination.
    Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 35. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

  • 37. SEROLOGICAL STUDY OF A MEASLES OUTBREAK IN AN INSTITUTION, TOKYO, 1962.
    NAKAMURA K; MINAMITANI M; FUJII R; YOKOTA A; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1963 Apr; 33():121-31. PubMed ID: 14057138
    [No Abstract]   [Full Text] [Related]  

  • 38. Field trial with a further attenuated live measles virus vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Kasahara N
    Jpn J Microbiol; 1973 Jan; 17(1):75-9. PubMed ID: 4540649
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
    Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
    N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
    [No Abstract]   [Full Text] [Related]  

  • 40. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.